Neurotrope, Inc. (NTRP) [Rocket]

In millions, except per share items	Sep-30-20	Jun-30-20	Mar-31-20	Dec-31-19	Sep-30-19	Jun-30-19	Mar-31-19	Dec-31-18
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Selling, general and administrative [+]	7.3	7.7	7.2	6.7	6.2	5.0	4.2	4.0
General and administrative [+]	7.3	7.7	7.2	6.7	6.2	5.0	4.2	4.0
General and administrative expenses	7.3	7.7	7.2	6.7	6.2	5.0	4.2	4.0
Research and development	1.3	1.7	2.8	4.5	6.4	7.3	6.4	4.6
Other operating expenses	-80.8	-82.7	-84.4	-26.0	-28.6	-27.6	-24.1	-19.5
EBITDA [+]	72.2	73.4	74.4	14.8	15.9	15.3	13.5	10.9
EBITDA growth	353.3%	378.6%	450.5%	35.4%	456.2%	-692.0%	-276.8%	-186.3%
Depreciation and amortization	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBIT [+]	72.2	73.4	74.4	14.8	15.9	15.3	13.5	10.9
EBIT growth	353.3%	378.7%	450.6%	35.4%	456.7%	-691.2%	-276.7%	-186.3%
Interest income	0.2	0.3	0.3	0.4	0.3	0.3	0.2	0.1
Interest income	0.2	0.3	0.3	0.4	0.3	0.3	0.2	0.1
Other income (expense), net [+]	1.7
Change in fair value of warrants	-1.7
Pre-tax income	74.1	73.7	74.7	15.1	16.3	15.6	13.7	11.0
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	12.4	11.9	13.0	15.1	16.3	15.6	13.7	11.0

Basic EPS [+]	$0.64	$0.72	$0.91	$1.17	$1.39	$1.49	$1.49	$1.39
Growth	-53.8%	-51.8%	-39.1%	-15.8%	267.2%	-569.5%	-254.4%	-184.0%
Diluted EPS [+]	$0.64	$0.72	$0.91	$1.17	$1.39	$1.49	$1.49	$1.39
Growth	-53.8%	-51.8%	-39.1%	-15.8%	267.2%	-569.5%	-254.4%	-184.0%

Shares outstanding (basic) [+]	19.3	16.6	14.3	12.9	11.7	10.5	9.2	7.9
Growth	64.5%	58.4%	55.3%	63.1%	49.1%	33.2%	17.5%	4.0%
Shares outstanding (diluted) [+]	19.3	16.6	14.3	12.9	11.7	10.5	9.2	7.9
Growth	64.5%	58.4%	55.3%	63.1%	49.1%	33.2%	17.5%	4.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.